Company Search:
Advanced Search
Sponsored Links
Getein Biotech Inc Company Snapshot
Getein Biotech Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Getein Biotech Inc with three other companies in this sector in China: BioSino Bio-technology and Science Inc (2016 sales of 325.39 million Chinese Renmimbi [US$51.36 million] ), Guangdong Hybribio Biotech Co Ltd (398.30 million Chinese Renmimbi [US$62.87 million] ), and Tellgen Corp (231.22 million Chinese Renmimbi [US$36.50 million] of which 92% was Reagent Income).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Getein Biotech Inc
  Stock Performance Chart for Getein Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 54.51
(Figures in Chinese Renmimbi)
1 Week -4.4%   13 Weeks 11.7%  
4 Weeks -6.8%   52 Weeks n/a  
Getein Biotech Inc Key Data:
  Ticker: 603387 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 369,090,357
(Year Ending Jan 2017).
Employees: 1,049
  Currency: Chinese Renmimbi Market Cap: 7,195,320,000
  Fiscal Yr Ends: December Shares Outstanding: 132,000,000
  Share Type: A Gu Closely Held Shares: 76,889,637
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.